Background Advantages of the arteriovenous fistula (AVF), including long patency and few
complications, were ascertained more than 2 decades ago and may not apply to the …

New guidelines for the management of chronic kidney disease have been developed by the
Canadian Society of Nephrology (Appendix 1 contains the fulltext guidelines; available at …

Vascular access dysfunction is one of the leading causes of morbidity and mortality among
end‐stage renal disease patients. Vascular access dysfunction exists in all three types of …

The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has
provided evidence-based guidelines for hemodialysis vascular access since 1996. Since the …

Residual renal function (RRF) in end-stage renal disease is clinically important as it
contributes to adequacy of dialysis, quality of life, and mortality. This study was conducted to …

Importance The effect of glucocorticoids on major kidney outcomes and adverse events in IgA
nephropathy has been uncertain. Objective To evaluate the efficacy and adverse effects of …

Fistulas are the preferred permanent hemodialysis vascular access but a significant obstacle
to increasing their prevalence is the fistula’s high “failure to mature”(FTM) rate. This study …

Several comparisons of peritoneal dialysis (PD) and hemodialysis (HD) in incident patients
with ESRD demonstrate superior survival in PD-treated patients within the first 1 to 2 years. …

Background The effectiveness of various solutions instilled into the central venous catheter
lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of …

Patients undergoing conventional maintenance hemodialysis typically receive three sessions
per week, each lasting 2.5–5.5 hours. Recently, the use of more intensive hemodialysis (> …